Hopes are high for a new and improved tuberculosis vaccine: Serum Institute of India is planning on taking a promising vaccine - originally developed in Germany - and introducing it into the clinical setting. Studies have shown that the new vaccine is more effective and better tolerated than currently available options. By signing a contract with the Hannover-based Vakzine Projekt Management GmbH, Serum, one of the World’s leading vaccine manufacturers, has effectively secured the license to the various patents and technologies related to the new vaccine.

Pyrazinamide resistance among Mycobacterium tuberculosis complex (MTBC) organisms increased from 2.0% in 1999 to 3.3% in 2009, according to a report from the U.S. Centers for Disease Control and Prevention.

Researchers at the University of Warwick have recovered tuberculosis (TB) genomes from the lung tissue of a 215-year old mummy using a technique known as metagenomics.

Rwanda is among the six countries that have achieved the recommendations of the 2006 Abuja Declaration of Head of States of African Union countries of allocating to health at least 15 per cent of their annual budget.

In Europe, tuberculosis (TB) is often considered a disease of the past, what people used to call 'consumption.' But in reality, TB remains with and among us.

Bethlehem, Pa — July 18, 2013 – Tuberculosis has been all but eradicated in the United States, yet is a massive killer worldwide, especially in developing countries. Currently, over 90 million sputum tests are conducted annually. The sputum test is less than 50% accurate and unable to diagnose many with active tuberculosis. With results no better than a coin toss, the World Health Organization (WHO) in 2011 recommended the use of ALL existing serological tests be discontinued. “The goal of TB Biosciences is to develop an accurate, easy to use, affordable, rapid point-of-care test to detect active Tuberculosis and replace the unreliable sputum smear” said Sam Niedbala, Ph.D., CEO and co-founder of TB Biosciences.